drug
NITROGLYCERIN
Marketedupdated 3mo agoby Allegis Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6indications
investigational
Hypertension
all catalysts(1)
Trials studying NITROGLYCERIN
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 12, 2029
~2.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Mar 11, 2032formulationUS 9101592
- Mar 12, 2029formulationUS 78720492.6y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that